Adherium Appoints SVP Business Development
This article was originally published in Scrip
Executive Summary
Adherium, an Australian company specialising in digital health technologies, has appointed John Tarplee, formerly of ALK-Abello, senior vice president of business development, Europe. Tarplee's appointment comes in conjunction with the establishment of Adherium Europe Ltd., which will operate from Guildford, UK. Tarplee has over 30 years' of experience in the industry, having previously held positions at Sanof-Aventis, Abbott Laboratories and Fison Pharmaceuticals.
You may also be interested in...
Big Pharma's Bad Attitude: Are CEOs Giving Industry A Bad Rep?
Big pharma has been big news recently, with politicians and the general public wading into industry debates on drug pricing, profit-making and trial transparency under the gleeful eye of the international press. Unsurprisingly, pharma has come out on the losing side of these debates, its scientific accomplishments forced into the shadows by the actions of executives such as Martin Shkreli, who have ensured that the spotlight is firmly on the people behind the businesses rather than the products they manufacture.
Pfizer's Martine J. George joins GarmaMabs
GarmaMabs Pharma has appointed Martine J. George an independent board member.
Mylan Appoints Kenneth Parks CFO
Mylan has appointed Kenneth Parks chief financial officer (CFO).